Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000947871-25-000165·ORBIMED ADVISORS LLC
Schedule 13G ownership disclosure
RAPT THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 75382E109
Event date: 2024-12-31
- Filing-level shares
- 13,135,260.00
- Percent of class
- 9.9%
- ORBIMED ADVISORS LLC
Shares: 13,135,260.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-25-000165
- Form type
- SCHEDULE 13G
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership